Table 1.
Gene\Model | VCaP | LNCaP | LAPC4 | |
---|---|---|---|---|
Cholesterol synthesis | ACAT2 | 1.0 | 3.3 (3.1–3.4)** | 2.1 (1.9–2.3)* |
HMGCS1 | − 1.1 | 2.1 (2.0–2.1)** | 2.8 (2.7–2.9)** | |
HMGCR | 1.6 | 1.9 | 2.1 (2.0–2.1)** | |
MVK | 1.5 | 2.3 (1.9–2.6)* | 2.4 (2.3–2.5)** | |
PMVK | 1.6 | 2.1 (2.0–2.2)** | 1.8 | |
MVD | 1.5 | 2.0 (1.9–2.0)** | 2.6 (2.5–2.6)** | |
FDFT1 | 1.3 | 3.2 (3.1–3.3)** | 2.4 (2.3–2.5)** | |
SQLE | 1.9 | 1.7 | 2.1 (2.0–2.1)** | |
uptake Cholesterol | SR-BI | 1.5 | 4.0 (3.8–4.2)** | 1.6 |
LDLR | 1.6 | 2.5 (2.5–2.5)** | 1.5 | |
LOX1 | −9.0 (8.1–10.0) ** | 1.5 | 1.9 | |
SREC | − 4.7 (3.8–5.8) * | 1.2 | 1.5 | |
STAR | − 4.7 (3.9–5.6) ** | 2.3 (2.1–2.4)** | 1.8 | |
steroidogenesis | CYP11A1 | − 8.2 (5.6–11.8) * | 1.3 | 1.7 |
HSD3B2 | 3.9 (3.6–4.3) ** | 1.2 | 1.9 | |
CYP17A1 | − 11.3(8.9–14.4)** | − 2.5 (2.4–2.6)** | − 1.9 | |
AKR1C3 | − 1.3 | − 1.3 | 6.9 (5.0–9.6)* | |
HSD17B3 | − 3.1 (1.6–5.7) * | − 5.6 (2.8–11.0)* | 1.8 | |
SRD5A1 | 1.1 | 1.9 | 3.0 (2.8–3.3)** | |
SRD5A2 | − 12.4(9.5–16.3)** | − 7.5 (5.2–10.8)* | 1.0 | |
SRD5A3 | − 1.8 | 2.2 (2.0–2.3)** | 1.6 | |
AKR1C2 | − 2.5 (2.3–2.8)** | − 1.8 | 5.6 (3.5–8.8)* | |
RDH5 | 1.0 | 2.3 (2.1–2.5)** | 1.3 |
p<0.05;
p<0.005, paired student’s t-test.